Pancreatic Cancer Research

ResearcherBrigham and Women's HospitalActive in the last 2 years

Paul Brennan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0518-8714; OpenAlex author ID A5001258652, A5158622740. Sources: OpenAlex.

Their work

Papers
33 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
96
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: 3 papers · 2019: 5 papers · 2020: 7 papers · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 4 papers

Papers 33

  1. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  2. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  3. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  4. Mutational signature landscape of pancreatic cancer genomes from nine countries Co-author DOI 10.64898/2026.10.21.26365999↗
  5. Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Co-author DOI 10.1371/journal.pmed.1004590↗
  6. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  7. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  8. ICGC-ARGO precision medicine: familial matters in pancreatic cancer. Co-author DOI 10.1016/s1470-2045(21)00703-8↗
  9. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  10. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  11. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  12. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Co-author DOI 10.1007/s10654-019-00559-6↗
  13. Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA. Co-author DOI 10.1016/j.ebiom.2019.09.042↗
  14. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  15. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  16. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  17. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  18. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study. Co-author DOI 10.1371/journal.pone.0243511↗
  19. CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation. Co-author DOI 10.1002/ijc.31900↗
  20. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy126↗
  21. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  22. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Co-author DOI 10.1158/1055-9965.epi-18-1235↗
  23. A Phenome-Wide Mendelian Randomization Study of Pancreatic Cancer Using Summary Genetic Data. Co-author DOI 10.1158/1055-9965.epi-19-0036↗
  24. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study. Co-author DOI 10.1002/ijc.31367↗
  25. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  26. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study. Co-author DOI 10.1158/1055-9965.epi-17-0592↗
  27. Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study. Co-author DOI 10.1002/ijc.30790↗
  28. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Co-author DOI 10.1093/annonc/mdx004↗
  29. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study. Last author DOI 10.1093/jnci/djx012↗
  30. KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control. Co-author DOI 10.18632/oncotarget.12386↗
  31. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  32. Physical activity and risk of pancreatic cancer in a central European multicenter case-control study. Co-author DOI 10.1007/s10552-014-0370-x↗
  33. Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study. Co-author DOI 10.1002/ijc.25959↗

Closest collaborators

The 25 strongest of 96 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ghislaine Scélo · 9 shared papers, 2011–2020 · strength 0.49
  2. Vladimí­r Janout · 6 shared papers, 2011–2020 · strength 0.32
  3. H. Bas Bueno-de-Mesquita · 4 shared papers, 2017–2020 · strength 0.22
  4. Eric J. Duell · 4 shared papers, 2017–2020 · strength 0.22
  5. Vinciane Rebours · 4 shared papers, 2017–2020 · strength 0.22
  6. Verena Andrea Katzke · 4 shared papers, 2017–2020 · strength 0.22
  7. Rudolf Kaaks · 4 shared papers, 2017–2020 · strength 0.22
  8. Malin Sund · 3 shared papers, 2018–2020 · strength 0.18
  9. Steve Gallinger · 2 shared papers, 2019–2022 · strength 0.17
  10. Akram Pourshams Md · 2 shared papers, 2018–2020 · strength 0.16
  11. Philip Haycock · 2 shared papers, 2017–2019 · strength 0.15
  12. Robert Carreras‐Torres · 2 shared papers, 2017–2019 · strength 0.15
  13. Florence Le Calvez‐Kelm · 2 shared papers, 2016–2020 · strength 0.14
  14. Samir Hanash · 2 shared papers, 2017–2019 · strength 0.12
  15. Anirban Maitra · 2 shared papers, 2017–2019 · strength 0.12
  16. Elio Ríboli · 2 shared papers, 2018–2020 · strength 0.12
  17. Sabine Naudin · 2 shared papers, 2018–2020 · strength 0.12
  18. Pietro Ferrari · 2 shared papers, 2018–2020 · strength 0.12
  19. Dagfinn Aune · 2 shared papers, 2017–2020 · strength 0.11
  20. Sahar Masoudi · 1 shared paper, 2020 · strength 0.10
  21. Neda Ghamarzad Shishavan · 1 shared paper, 2020 · strength 0.10
  22. Mahdi SHEIKH · 1 shared paper, 2020 · strength 0.10
  23. Saman Nikeghbalian · 1 shared paper, 2020 · strength 0.10
  24. Paolo Vineis · 2 shared papers, 2017–2019 · strength 0.10
  25. Amber L. Johns · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.